Further analysis of scRNA-seq data showed that monocytic AML cells surviving VEN treatment demonstrated the highest sphingolipid metabolism score, particularly in CD14+ITGAX+ monocytic AML cells. The gene discussed is ITGAX; the disease is acute myeloid leukemia.